Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Are Rates of Methicillin-Resistant Staphylococcus aureus and Clostridioides difficile Associated With Quality and Clinical Outcomes in US Acute Care Hospitals?

Tytuł:
Are Rates of Methicillin-Resistant Staphylococcus aureus and Clostridioides difficile Associated With Quality and Clinical Outcomes in US Acute Care Hospitals?
Autorzy:
Garcia Reeves AB; University of North Carolina, Chapel Hill, NC North Carolina Department of Health and Human Services, Raleigh, NC.
Trogdon JG
Stearns SC
Lewis JW
Weber DJ
Weinberger M
Źródło:
American journal of medical quality : the official journal of the American College of Medical Quality [Am J Med Qual] 2021 Mar-Apr 01; Vol. 36 (2), pp. 90-98.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2021- : [Alphen aan den Rijn, the Netherlands] : Wolters Kluwer Health
Original Publication: Baltimore, MD : Williams & Wilkins, c1992-
MeSH Terms:
Cross Infection*/epidemiology
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections*/drug therapy
Staphylococcal Infections*/epidemiology
Aged ; Clostridioides ; Hospitals ; Humans ; Medicare ; United States/epidemiology
References:
Oz T, Guvenek A, Yildiz S, et al. Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution. Mol Biol Evol. 2014; 31:2387–2401. doi: 10.1093/molbev/msu191.
Kourtis A, Hatfield K, Baggs J, et al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. MMWR Morb Mortal Wkly Rep. 2019; 68:214–219. doi: 10.15585/mmwr.mm6809e1.
Lessa F, Mu Y, Bamberg W, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015; 372:825–834. doi: 10.1056/NEJMc1505190.
Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007; 60:913–920. doi:10.1093/jac/dkm318.
Macvane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med. 2014; 9:232–238. doi:10.1002/jhm.2157.
Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003; 36:1433–1437. doi:10.1086/375081.
Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018; 7:58. doi:10.1186/s13756-018-0336-y.
Johnston K, Thorpe K, Jacob J, Murphy D. The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting—a national estimate. Health Serv Res. 2019; 54:782–792. doi:10.1111/1475-6773.13135.
Lee J, Austin J, Kim J, et al. Developing and testing a chart abstraction tool for ICU quality measurement. Am J Med Qual. 2019; 34:324–330. doi:10.1177/1062860618800596.
Klein EY, Jiang W, Mojica N, et al. National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010-2014. Clin Infect Dis. 2019; 68:22–28. doi:10.1093/cid/ciy399.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003; 36:53–59. doi:10.1086/377611.
Emerson CB, Eyzaguirre LM, Albrecht JS, Comer C, Harris AD, Furuno JP. Healthcare-associated infection and hospital readmission. Infect Control Hosp Epidemiol. 2012; 33:539–544. doi: 10.1086/665725.
Chiew CJ, Ho HJ, Win MK, et al. Persistence of methicillin-resistant Staphylococcus aureus carriage in re-admitted patients. J Hosp Infect. 2018; 100:350–354. doi:10.1016/J.JHIN.2018.04.001.
Burnham JP, Kwon JH, Olsen MA, Babcock HM, Kollef MH. Readmissions with multidrug-resistant infection in patients with prior multidrug-resistant infection. Infect Control Hosp Epidemiol. 2018; 39:12–19. doi:10.1017/ice.2017.254.
Inagaki K, Lucar J, Blackshear C, Hobbs C V. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis. 2019; 69:2112–2118. doi:10.1093/cid/ciz123.
Andreassen AES, Jacobsen CM, de Blasio BF, White R, Kristiansen IS, Elstrøm P. The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway. Antimicrob Resist Infect Control. 2017; 6:1–8. doi:10.1186/s13756-017-0232-x.
Campbell RS, Emons MF, Mardekian J, Girgenti D, Gaffney M, Yu H. Adverse clinical outcomes and resource utilization associated with methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections after elective surgery. Surg Infect (Larchmt). 2015; 16:543–552. doi:10.1089/sur.2013.250.
Tran K, Bell C, Stall N, et al. The effect of hospital isolation precautions on patient outcomes and cost of care: a multi-site, retrospective, propensity score-matched cohort study. J Gen Intern Med. 2017; 32:262–268. doi:10.1007/s11606-016-3862-4.
Yaw LK, Robinson JO, Ho KM. A comparison of long-term outcomes after methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis. 2014; 14:967–975. doi:10.1016/S1473-3099(14)70876-X.
Barrasa-Villar J, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis. 2017; 65:644–652. doi:10.1093/cid/cix411.
Lowy I, Molrine D, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010; 362:197–205. doi:10.1056/NEJMoa0907635.
Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013; 56:67–73. doi:10.1093/cid/cis840.
Deshpande A, Pant C, Olyaee M, Donskey CJ. Hospital readmissions related to Clostridium difficile infection in the United States. Am J Infect Control. 2018; 46:346–347. doi:10.1016/J.AJIC.2017.08.043.
Miller M, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol. 2002; 23:137–140. doi:10.1086/502023.
Datta R, Brown S, Nguyen VQ, et al. Quantifying the exposure to antibiotic-resistant pathogens among patients discharged from a single hospital across all California healthcare facilities. Infect Control Hosp Epidemiol. 2015; 36:1275–1282. doi:10.1017/ice.2015.181.
Dinh A, Le Monnier A, Emery C, et al. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study. Eur J Clin Microbiol Infect Dis. 2019; 38:1297–1305.
Psoinos CM, Collins CE, Ayturk MD, Anderson FA, Santry HP. Post-hospitalization treatment regimen and readmission for C. difficile colitis in Medicare beneficiaries. World J Surg. 2018; 42:246–253.
Ayau P, Bardossy AC, Sanchez G, et al. Risk factors for 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. Int J Infect Dis. 2017; 61:3–6. doi:10.1016/j.ijid.2017.05.010.
Li C, Duan J, Liu S, et al. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a university hospital in Central China. Infection. 2017; 45:621–628. doi:10.1007/s15010-017-1024-1.
Le J, Dam Q, Tran T, et al. Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period. Epidemiol Infect. 2017; 145:2631–2639. doi:10.1017/s0950268817001571.
Chatterjee A, Rai S, Guddattu V, Mukhopadhyay C, Saravu K. Is methicillin-resistant Staphylococcus aureus infection associated with higher mortality and morbidity in hospitalized patients? A cohort study of 551 patients from south western India. Risk Manag Healthc Policy. 2018; 11:243–250. doi:10.2147/rmhp.s176517.
Qiao F, Huang W, Cai L, Zong Z, Yin W. Methicillin-resistant Staphylococcus aureus nasal colonization and infection in an intensive care unit of a university hospital in China. J Int Med Res. 2018; 46:3698–3708. doi:10.1177/0300060518777812.
Balsells E, Shi T, Leese C, et al. Global burden of Clostridium difficile infections: a systematic review and meta-analysis. J Glob Health. 2019; 91010407. doi:10.7189/jogh.09.010407.
Entry Date(s):
Date Created: 20200721 Date Completed: 20211124 Latest Revision: 20211124
Update Code:
20240104
DOI:
10.1177/1062860620942310
PMID:
32686484
Czasopismo naukowe
The purpose of this study was to examine the association between rates of methicillin-resistant Staphylococcus aureus (MRSA)/Clostridioides difficile and quality and clinical outcomes in US acute care hospitals. The population was all Medicare-certified US acute care hospitals with MRSA/C difficile standardized infection ratio (SIR) data available from 2013 to 2017. Hospital-level data from the Centers for Medicare & Medicaid Services were used to estimate hospital and time fixed effects models for 30-day hospital readmissions, length of stay, 30-day mortality, and days in the intensive care unit. The key explanatory variables were SIR for MRSA and C difficile. No association was found between MRSA or C difficile rates and any of the 4 outcomes. The null results add to the mixed evidence in the field, but there are likely residual confounding factors. Future research should use larger samples of patient-level data and appropriate methods to provide evidence to guide efforts to tackle antimicrobial resistance.
(Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies